Otonomy Announces Assignment of J Code for OTIPRIO®
Nov 02, 2016 11:30 am UTC| Business
SAN DIEGO, Nov. 02, 2016 -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced...
Cidara Therapeutics and Square 1 Bank Announce $20 Million Credit Facility
Nov 02, 2016 11:30 am UTC| Business
SAN DIEGO, Nov. 02, 2016 -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections, and Square 1 Bank, a division of...
iCAD Reports Third Quarter 2016 Financial Results
Nov 02, 2016 11:30 am UTC| Business
NASHUA, N.H., Nov. 02, 2016 -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today...
MGP Ingredients Reports Third Quarter Results
Nov 02, 2016 11:30 am UTC| Business
ATCHISON, Kan., Nov. 02, 2016 -- MGPIngredients, Inc. (Nasdaq:MGPI), a leading supplier of premium distilled spirits and specialty wheat proteins and starches, today reported results for the third quarter ended...
Nov 02, 2016 11:30 am UTC| Business
Successfully demonstrated proof-of-principle in a Phase 1b study of oral and IV omadacycline in patients with urinary tract infections (UTI)Completed all clinical phase 1 studies and registration batches required for NDA...
Och-Ziff Reports 2016 Third Quarter Results
Nov 02, 2016 11:30 am UTC| Business
NEW YORK, Nov. 02, 2016 -- Och-Ziff Capital Management Group LLC (NYSE:OZM) announced its 2016 third quarter results today. To view the detailed earnings press release, please visit the Public Investors page of...
Edge Therapeutics to Present at Investor Conferences in November
Nov 02, 2016 11:30 am UTC| Business
BERKELEY HEIGHTS, N.J., Nov. 02, 2016 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions,...